137 related articles for article (PubMed ID: 6610200)
21. Effects of vasopressin on the intravariceal pressure in patients with cirrhosis: comparison with the effects on portal pressure.
Bosch J; Bordas JM; Mastai R; Kravetz D; Navasa M; Chesta J; Pizcueta MP; García-Pagán JC; Rodés J
Hepatology; 1988; 8(4):861-5. PubMed ID: 3391513
[TBL] [Abstract][Full Text] [Related]
22. Effects of isosorbide-5-mononitrate on variceal pressure and systemic and splanchnic haemodynamics in patients with cirrhosis.
Escorsell A; Feu F; Bordas JM; García-Pagán JC; Luca A; Bosch J; Rodés J
J Hepatol; 1996 Apr; 24(4):423-9. PubMed ID: 8738728
[TBL] [Abstract][Full Text] [Related]
23. Effect of vasopressin on portal venous pressure.
Kallio H; Lempinen M
Acta Chir Scand; 1983; 149(1):49-52. PubMed ID: 6601347
[TBL] [Abstract][Full Text] [Related]
24. Effects of vasopressin on left gastric venous flow in cirrhotic patients with esophageal varices.
Ohnishi K; Sato S
Am J Gastroenterol; 1990 Mar; 85(3):293-5. PubMed ID: 2178400
[TBL] [Abstract][Full Text] [Related]
25. Vasopressin: route of administration and effects on canine hepatic and superior mesenteric arterial blood flows.
Kerr JC; Hobson RW; Seelig RF; Swan KG
Ann Surg; 1978 Feb; 187(2):137-42. PubMed ID: 147062
[TBL] [Abstract][Full Text] [Related]
26. Vasopressin perfusion of esophageal varices in cirrhotic patients: cineangiographic study.
Valla D; Huet PM; LaFortune M; Marleau D
Radiology; 1984 Jul; 152(1):45-9. PubMed ID: 6610186
[TBL] [Abstract][Full Text] [Related]
27. 48-hour hemodynamic effects of octreotide on postprandial splanchnic hyperemia in patients with liver cirrhosis and portal hypertension: double-blind, placebo-controlled study.
Ludwig D; Schädel S; Brüning A; Schiefer B; Stange EF
Dig Dis Sci; 2000 May; 45(5):1019-27. PubMed ID: 10795771
[TBL] [Abstract][Full Text] [Related]
28. Measurement of azygos venous blood flow in the evaluation of portal hypertension in patients with cirrhosis. Clinical and haemodynamic correlations in 100 patients.
Bosch J; Mastai R; Kravetz D; Bruix J; Rigau J; Rodés J
J Hepatol; 1985; 1(2):125-39. PubMed ID: 3877113
[TBL] [Abstract][Full Text] [Related]
29. The effect of vasopressin and triglycyl lysine vasopressin (glypressin) on the splanchnic circulation in cirrhotic patients with portal hypertension.
Rabol A; Juhl E; Schmidt A; Winkler K
Digestion; 1976; 14(3):285-9. PubMed ID: 955334
[TBL] [Abstract][Full Text] [Related]
30. Portal and systemic effects of selective infusion of vasopressin into the superior mesenteric artery in cirrhotic patients.
Millette B; Huet PM; Lavoie P; Viallet A
Gastroenterology; 1975 Jul; 69(1):6-12. PubMed ID: 1150036
[TBL] [Abstract][Full Text] [Related]
31. Similarity of arterial and intravenous vasopressin on portal and systemic hemodynamics.
Barr JW; Lakin RC; Rösch J
Gastroenterology; 1975 Jul; 69(1):13-9. PubMed ID: 1150017
[TBL] [Abstract][Full Text] [Related]
32. The effect of vasopressin on hepatic artery flow in the rat.
Jenkins SA; Mooney B; Devitt P; Taylor I; Shields R
Clin Exp Pharmacol Physiol; 1984; 11(5):521-6. PubMed ID: 6525767
[TBL] [Abstract][Full Text] [Related]
33. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.
Bosch J; Kravetz D; Rodes J
Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897
[TBL] [Abstract][Full Text] [Related]
34. Effect of somatostatin on splanchnic hemodynamics in patients with liver cirrhosis and portal hypertension.
Merkel C; Gatta A; Zuin R; Finucci GF; Nosadini R; Ruol A
Digestion; 1985; 32(2):92-8. PubMed ID: 2864299
[TBL] [Abstract][Full Text] [Related]
35. Effects of dobutamine on hepatosplanchnic hemodynamics in patients with chronic liver disease.
Kawasaki T; Moriyasu F; Kimura T; Someda H; Hamato N; Okuma M
Scand J Gastroenterol; 1994 Nov; 29(11):1044-54. PubMed ID: 7871372
[TBL] [Abstract][Full Text] [Related]
36. The influence of a long-acting somatostatin analogue on splanchnic haemodynamics and metabolism in healthy subjects and patients with liver cirrhosis.
Wahren J; Eriksson LS
Scand J Gastroenterol Suppl; 1986; 119():103-8. PubMed ID: 2876492
[TBL] [Abstract][Full Text] [Related]
37. Hemodynamic effects of vasopressin, alone and in combination with nitroprusside, in patients with liver cirrhosis and portal hypertension.
Mols P; Hallemans R; Van Kuyk M; Melot C; Lejeune P; Ham H; Vertongen F; Naeije R
Ann Surg; 1984 Feb; 199(2):176-81. PubMed ID: 6696534
[TBL] [Abstract][Full Text] [Related]
38. The effects of the combination of phentolamine and vasopressin on hepatic and systemic hemodynamics in cirrhotic portal hypertensive dog model.
Dan ZL; Zhao Q; Li SB
J Tongji Med Univ; 1991; 11(1):35-8. PubMed ID: 1875450
[TBL] [Abstract][Full Text] [Related]
39. Effects of vasopressin on portal hemodynamics in patients with portal hypertension.
Ohnishi K; Saito M; Nakayama T; Hatano H; Okuda K
Am J Gastroenterol; 1987 Feb; 82(2):135-8. PubMed ID: 2949601
[TBL] [Abstract][Full Text] [Related]
40. A lethal complication of peripheral vein vasopressin infusion.
Brearley S; Hawker PC; Dykes PW; Keighley MR
Hepatogastroenterology; 1985 Oct; 32(5):224-5. PubMed ID: 3878320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
